Page last updated: 2024-08-22

2-methoxy-1,4-naphthoquinone and ER-Negative PR-Negative HER2-Negative Breast Cancer

2-methoxy-1,4-naphthoquinone has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Daud, SM; Fauzi, AN; Yaacob, NS1

Other Studies

1 other study(ies) available for 2-methoxy-1,4-naphthoquinone and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
2-Methoxy-1,4-Naphthoquinone (MNQ) Inhibits Glucose Uptake and Lactate Production in Triple-Negative Breast Cancer Cells.
    Asian Pacific journal of cancer prevention : APJCP, 2021, Feb-01, Volume: 22, Issue:S1

    Topics: Antineoplastic Agents; Cell Survival; Female; Glucose; Glycolysis; Humans; Lactic Acid; Naphthoquinones; Triple Negative Breast Neoplasms; Tumor Cells, Cultured

2021